Long‐Term Quality of Life and Survivorship Priorities in Esophageal Cancer Patients: A Survey‐Based Assessment
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Edward A Joseph und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Allegheny Health Network Singer Research Institute, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Quality of Life, Esophageal Neoplasms, Survivorship, Cancer Survivors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and Objectives This study examines the long‐term quality of life (QOL) and priorities of survivors who underwent management for esophageal cancer (EC).
Methods
We cross‐sectionally surveyed EC patients through online support groups to assess the relative importance of their overall survival, experience, costs of care, and QOL. Kendall's co‐efficient of Concordance (W) was utilized to assess agreement among respondents.
Results
Among 100 respondents (age 57.2 ± 10.4 years, 54% male, 90% Caucasian), median overall survival was 18.0 (7.8–49.8) months, with a maximum survivorship of 48.3 years. Respondents ranked overall survival most important, followed by functional independence, emotional well‐being, treatment experience, and costs of care (W = 0.342, p < 0.001). Some survivors ranked treatment experience (4%) or costs (6%) as their most important priority. The cohort's physical QOL (P‐QOL; 39.79 ± 10.16) and mental QOL (M‐QOL; 42.29 ± 15.43) were below that of the general population (50.00 ± 10.00); both p < 0.050. There was no difference in P‐QOL and M‐QOL based on the presence of metastatic disease (both p > 0.050). Patients who underwent curative surgery had superior M‐QOL (45.00 ± 15.22 vs. 36.70 ± 14.53, p = 0.010). Although P‐QOL was similar based on duration of survival (40.30 ± 9.75 [< 1 year], 39.33 ± 10.52 [1–5 years], 39.81 ± 10.68 [> 5 years], p = 0.873), M‐QOL was higher in patients with extended survivorship (36.87 ± 14.24 [< 1 year], 45.05 ± 14.94 [1–5 years], 47.30 ± 16.36 [> 5 years], p = 0.008).
Conclusions
Despite enduring physical health impairments, a majority of EC survivors prioritized their survival. However, a few survivors prioritized costs and treatment experience, underscoring the importance of tailoring treatments to ensure alignment with individual patient‐driven priorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Allegheny Health Network Singer Research Institute, Pittsburgh, Pennsylvania, USA.
- Division of Surgical Oncology, Institute of Surgery, Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA.
Zitieren
APA
Joseph, E. A., & Allen, C. J. (2025). Long‐Term Quality of Life and Survivorship Priorities in Esophageal Cancer Patients: A Survey‐Based Assessment. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28045
Vancouver
Joseph EA, Allen CJ. Long‐Term Quality of Life and Survivorship Priorities in Esophageal Cancer Patients: A Survey‐Based Assessment. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28045
BibTeX
@article{Joseph2025,
author = {Joseph, Edward A and Allen, Casey J},
title = {Long‐Term Quality of Life and Survivorship Priorities in Esophageal Cancer Patients: A Survey‐Based Assessment},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28045}
}
EUVIMED